Myelodysplastic syndromes and related disorders (myelodysplasia) are a heterogeneous group of myeloid neoplasms showing deregulated blood cell production with evidence of myeloid dysplasia and a predisposition to acute myeloid leukaemia, whose pathogenesis is only incompletely understood. Here we report whole-exome sequencing of 29 myelodysplasia specimens, which unexpectedly revealed novel pathway mutations involving multiple components of the RNA splicing machinery, including U2AF35, ZRSR2, SRSF2 and SF3B1. In a large series analysis, these splicing pathway mutations were frequent (~45 to ~85%) in, and highly specific to, myeloid neoplasms showing features of myelodysplasia. Conspicuously, most of the mutations, which occurred in a mutually exclusive manner, affected genes involved in the 3′-splice site recognition during pre-mRNA processing, inducing abnormal RNA splicing and compromised haematopoiesis. Our results provide the first evidence indicating that genetic alterations of the major splicing components could be involved in human pathogenesis, also implicating a novel therapeutic possibility for myelodysplasia.
At a glance
- Myelodysplastic syndromes: the complexity of stem-cell diseases. Nature Rev. Cancer 7, 118–129 (2007) et al.
- Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109, 1536–1542 (2007) , , &
- Unraveling the molecular pathophysiology of myelodysplastic syndromes. J. Clin. Oncol. 29, 504–515 (2011) , &
- Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature 460, 904–908 (2009) et al.
- Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genet. 40, 722–729 (2008) et al.
- Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467–472 (2011) et al.
- The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465, 473–477 (2010) et al.
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66–72 (2008) et al.
- Sequencing technologies — the next generation. Nature Rev. Genet. 11, 31–46 (2010)
- Next-generation DNA sequencing. Nature Biotechnol. 26, 1135–1145 (2008) &
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809–813 (2009) et al.
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539–542 (2011) et al.
- DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424–2433 (2010) et al.
- Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058–1066 (2009) et al.
- Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genet. 43, 309–315 (2011) et al.
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101–105 (2011) et al.
- A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 65, 6071–6079 (2005) et al.
- Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of Affymetrix single-nucleotide-polymorphism genotyping microarrays. Am. J. Hum. Genet. 81, 114–126 (2007) et al.
- The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701–718 (2009) , &
- A protein related to splicing factor U2AF35 that interacts with U2AF65 and SR proteins in splicing of pre-mRNA. Nature 388, 397–400 (1997) , &
- A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature 468, 1061–1066 (2010) et al.
- High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nature Genet. 42, 851–858 (2010) et al.
- New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110, 4385–4395 (2007) et al.
- Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol. Cell. Biol. 27, 5393–5402 (2007) et al.
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genet. 42, 181–185 (2010) et al.
- Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005) et al.
- Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nature Rev. Mol. Cell Biol. 5, 89–99 (2004)
- Adult mouse hematopoietic stem cells: purification and single-cell assays. Nature Protocols 1, 2979–2987 (2007) et al.
- Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nature Rev. Mol. Cell Biol. 10, 741–754 (2009) &
- Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev. 21, 708–718 (2007) et al.
- Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I. Science 332, 238–240 (2011) et al.
- Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA. Science 332, 240–243 (2011) et al.
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 24, 2343–2364 (2010) &
- Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol. 8, 349–357 (2007) et al.
- The U2AF35-related protein Urp contacts the 3′ splice site to promote U12-type intron splicing and the second step of U2-type intron splicing. Genes Dev. 24, 2389–2394 (2010) , , &
- A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q− syndrome. Nature Med. 16, 59–66 (2010) et al.
- Identification of RPS14 as a 5q− syndrome gene by RNA interference screen. Nature 451, 335–339 (2008) et al.
- Supplementary Information (7.1M)
This file contains Supplementary Methods 1-8 (see Contents for more details), additional references, Supplementary Figures 1-18 with legends and Supplementary Tables 1-11.